Tag: Matthew Yeowart
Firms act on Hengrui-GSK USD12.5bn drug development deal
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
English
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
Trade secret protection under TSA and IPCAA: Secrecy, value, confidentiality measures and Supreme Court guidance
Follow us on LinkedIn